A detailed history of Deerfield Management Company, L.P. (Series C) transactions in Edgewise Therapeutics, Inc. stock. As of the latest transaction made, Deerfield Management Company, L.P. (Series C) holds 1,781,006 shares of EWTX stock, worth $51.2 Million. This represents 0.88% of its overall portfolio holdings.

Number of Shares
1,781,006
Previous 2,874,586 38.04%
Holding current value
$51.2 Million
Previous $51.8 Million 8.18%
% of portfolio
0.88%
Previous 1.09%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$15.88 - $29.5 $17.4 Million - $32.3 Million
-1,093,580 Reduced 38.04%
1,781,006 $47.5 Million
Q1 2024

May 15, 2024

SELL
$9.25 - $19.97 $9.79 Million - $21.1 Million
-1,058,551 Reduced 26.91%
2,874,586 $52.4 Million
Q1 2021

May 17, 2021

BUY
$30.0 - $35.99 $118 Million - $142 Million
3,933,137 New
3,933,137 $128 Million

Others Institutions Holding EWTX

About Edgewise Therapeutics, Inc.


  • Ticker EWTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 63,171,700
  • Market Cap $1.82B
  • Description
  • Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. The Company's lead product candidate, EDG-5506, is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy which has c...
More about EWTX
Track This Portfolio

Track Deerfield Management Company, L.P. (Series C) Portfolio

Follow Deerfield Management Company, L.P. (Series C) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deerfield Management Company, L.P. (Series C), based on Form 13F filings with the SEC.

News

Stay updated on Deerfield Management Company, L.P. (Series C) with notifications on news.